Ali Salehi Farid (A Salehi Farid)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Randomized Controlled Trial

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Monoclonal Antibody

Top Venues

Dermatologic therapy

The Journal of dermatological treatment

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Fröse, Jennifer E Rowley, Ali Salehi Farid, Taha Rakhshandehroo, Paul Leclerc, Howard H Mak, Harris H Allen, Heydar Moravej, Leila Munaretto, Luis R Millán-Barea, Elisabeth Codet, Hannah Glockner, Caron Jacobson, Michael T Hemann, Mohammad Rashidian
Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool. Science advances 10 (38) (2024)
Hamid Reza Mahmoudi, Roja Toosi, Ali Salehi Farid, Maryam Danespazhooh
Pemphigus Disease and Area Index: Unmet needs in the real-world management of pemphigus. Oral diseases (2023)
Ahmad Vafaeian, Arefeh Ghanbarzadeh, Maryam Danespazhooh, Robabeh Abedini, Kamran Balighi, Ifa Etesami, Ali Salehi Farid, Zeinab Farimani, Leila Mahmoudi, Pedram Molhem Azar, Hamid Reza Mahmoudi
Nail abnormalities in subepidermal blistering diseases: a cross-sectional study. International journal of dermatology (2023)
Fateme Shirzad Moghadam, Nika Kianfar, Shayan Dasdar, Rana Samii, Zeinab Farimani, Pedram Molhem Azar, Kamran Balighi, Robabeh Abedini, Tahereh Soori, Ali Salehi Farid, Hamid Reza Mahmoudi, Maryam Danespazhooh
Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: A historical cohort study. Dermatologic therapy 35 (9) (2022)
Ali Nili, Shakiba Karimi, Ali Salehi Farid, Pedram Molhem Azar, Zeinab Farimani, Haneyeh Shahbazian, Kamran Balighi, Soheil Tavakolpour, Hamid Reza Mahmoudi, Maryam Danespazhooh
Factors associated with the healing time of pemphigus vulgaris oral lesions: A prospective study. Oral diseases (2022)
Mohammad Al Salman, Maryam Ghiasi, Ali Salehi Farid, Mohammad Taraz, Arghavan Azizpour, Hamid Reza Mahmoudi
Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: A randomized controlled trial. Dermatologic therapy 34 (5) (2021)
Hamid Reza Mahmoudi, Ali Nili, Ali Salehi Farid, Soheil Tavakolpour, Maryam Danespazhooh
Paradoxical worsening of pemphigus after rituximab presenting as figurate bullous eruption. The British journal of dermatology 185 (1) (2021)
Maryam Danespazhooh, Soheil Tavakolpour, Ali Salehi Farid, Mehrnoosh Ebadi, Ali Nili, Mohammad Rashidian, Hamid Reza Mahmoudi
Pustular eruption after biosimilar rituximab infusion: report of acute generalized exanthematous pustulosis in two patients with pemphigus. International journal of dermatology 61 (1) (2021)
Ali Nili, Ali Salehi Farid, Masoud Asgari, Soheil Tavakolpour, Hamid Reza Mahmoudi, Maryam Danespazhooh
Current status and prospects for the diagnosis of pemphigus vulgaris. Expert review of clinical immunology 17 (8) (2021)
Ali Salehi Farid, Somayeh Niknam, Kheirollah Gholami, Soheil Tavakolpour, Amir Teimourpour, Maryam Danespazhooh, Ali Nili, Arghavan Azizpour, Maryam Nasimi, Hamid Reza Mahmoudi
Comparing efficacy and safety of potassium hydroxide 5% solution with 5-fluorouracil cream in patients with actinic keratoses: a randomized controlled trial. The Journal of dermatological treatment (2020)
Ali Nili, Hamid Reza Mahmoudi, Nikta Heidari, Soheil Tavakolpour, Ali Salehi Farid, Kamran Balighi, Maryam Danespazhooh
Rituximab monotherapy in mild pemphigus. The Journal of dermatological treatment (2020)
Hamid Reza Mahmoudi, Soheil Tavakolpour, Kamran Balighi, Ali Salehi Farid, Ali Nili, Delnavaz Jan, Maryam Danespazhooh
Rituximab in practice: Clinical evaluation of patients with pemphigus after rituximab administration. Dermatologic therapy 34 (1) (2020)
Hamid Reza Mahmoudi, Anahita Rostami, Soheil Tavakolpour, Ali Nili, Amir Teimourpour, Ali Salehi Farid, Robabeh Abedini, Mohammad Amini, Maryam Danespazhooh
Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial. The Journal of dermatological treatment (2020)
Mahsa Fallahi, Zahra Hallaji, Soheil Tavakolpour, Somayeh Niknam, Ali Salehi Farid, Ali Nili, Amir Teimourpour, Maryam Danespazhooh, Javad Rahmati, Shahriar Haddady Abianeh, Hamid Reza Mahmoudi
Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial. Journal of cosmetic dermatology 20 (8) (2020)